Overview
Availability
- Dr Emily Strong is:
- Available for supervision
Qualifications
- Doctor of Philosophy, University of Queensland
Works
Search Professor Emily Strong’s works on UQ eSpace
2024
Journal Article
Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis
Wang, XinYue, Jowsey, William J., Cheung, Chen-Yi, Smart, Caitlan J., Klaus, Hannah R., Seeto, Noon EJ, Waller, Natalie JE, Chrisp, Michael T., Peterson, Amanda L., Ofori-Anyinam, Boatema, Strong, Emily, Nijagal, Brunda, West, Nicholas P., Yang, Jason H., Fineran, Peter C., Cook, Gregory M., Jackson, Simon A. and McNeil, Matthew B. (2024). Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis. Nature Communications, 15 (1) 9791, 9791. doi: 10.1038/s41467-024-54072-w
2024
Journal Article
Identification of axinellamines A and B as anti-tubercular agents
Strong, Emily J., Tan, Lendl, Hayes, Sasha, Whyte, Hayden, Davis, Rohan A. and West, Nicholas P. (2024). Identification of axinellamines A and B as anti-tubercular agents. Marine Drugs, 22 (7) 298. doi: 10.3390/md22070298
2024
Journal Article
Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides
Farr, Dylan C., Haselhorst, Thomas, Tan, Lendl, Furness, Juanelle, Strong, Emily, Grice, I. Darren, West, Nicholas P. and Houston, Todd A. (2024). Reassessing the putative molecular Target(s) of potent antitubercular 2-(Alkylsulfonyl)acetamides. European Journal of Medicinal Chemistry, 264 115983, 1-12. doi: 10.1016/j.ejmech.2023.115983
2023
Conference Publication
Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs
Paez, Reina N., Browning, Sarah, Files, Megan A., Varghese, Alyssa A., Huante, Matthew B., Strong, Emily, Lee, Sunhee, Endsley, Mark A. and Endsley, Janice J. (2023). Macrophage plasticity and activation states drive differential expression of murine macrophage galactose-type lectin (MGL) orthologs. Annual Meeting of the American Association of Immunologists (AAI), Washington, DC United States, 11-15 May 2023. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.210.Supp.160.32
2022
Journal Article
FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy
Wang, Jia, Sha, Jian, Strong, Emily, Chopra, Ashok K. and Lee, Sunhee (2022). FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy. Microbiology Spectrum, 10 (5). doi: 10.1128/spectrum.02509-22
2022
Journal Article
Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy
Gonzalez-Orozco, Maria, Strong, Emily J., Paroha, Ruchi and Lee, Sunhee (2022). Reversing BCG-mediated autophagy inhibition and mycobacterial survival to improve vaccine efficacy. BMC Immunology, 23 (1) 43. doi: 10.1186/s12865-022-00518-z
2022
Journal Article
Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling
Strong, Emily J., Wang, Jia, Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2022). Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling. MBio, 13 (3). doi: 10.1128/mbio.02974-21
2022
Journal Article
Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo
Strong, Emily, Hart, Bryan, Wang, Jia, Orozco, Maria Gonzalez and Lee, Sunhee (2022). Induced synthesis of mycolactone restores the pathogenesis of Mycobacterium ulcerans in vitro and in vivo. Frontiers in Immunology, 13 750643. doi: 10.3389/fimmu.2022.750643
2021
Journal Article
Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A
Strong, Emily J., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2021). Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 proteins inhibit autophagy by interaction with Rab1A. Msphere, 6 (4), 1-17. doi: 10.1128/msphere.00549-21
2021
Journal Article
Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria
Strong, Emily J. and Lee, Sunhee (2021). Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria. Frontiers in Microbiology, 11 614313. doi: 10.3389/fmicb.2020.614313
2020
Journal Article
Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening
Strong, Emily J., Jurcic Smith, Kristen L., Saini, Neeraj K., Ng, Tony W., Porcelli, Steven A. and Lee, Sunhee (2020). Identification of autophagy-inhibiting factors of mycobacterium tuberculosis by high-throughput loss-of-function screening. Infection and Immunity, 88 (12) e00269-20. doi: 10.1128/IAI.00269-20
2018
Journal Article
Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method
Tan, Lendl, Strong, Emily J., Woods, Kyra and West, Nicholas P. (2018). Homologous alignment cloning: a rapid, flexible and highly efficient general molecular cloning method. PeerJ, 6 (6) e5146, e5146. doi: 10.7717/peerj.5146
2018
Journal Article
Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis
Strong, Emily J. and West, Nicholas P. (2018). Use of soluble extracellular regions of MmpL (SERoM) as vaccines for tuberculosis. Scientific Reports, 8 (1) 5604, 5604. doi: 10.1038/s41598-018-23893-3
2017
Other Outputs
A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection
Strong, Emily (2017). A Functional Genomics Approach to Vaccine Development Against Mycobacterium tuberculosis and the Role MmpL13 Plays in Tuberculosis Infection. PhD Thesis, School of Chemistry & Molecular Biosciences, The University of Queensland. doi: 10.14264/uql.2017.1037
2016
Journal Article
Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells
Dando, Samantha J., Ipe, Deepak S., Batzloff, Michael, Sullivan, Matthew J., Crossman, David K., Crowley, Michael, Strong, Emily, Kyan, Stephanie, Leclercq, Sophie Y., Ekberg, Jenny A. K., St John, James, Beacham, Ifor R. and Ulett, Glen C. (2016). Burkholderia pseudomallei capsule exacerbates respiratory melioidosis but does not afford protection against antimicrobial signaling or bacterial killing in human olfactory ensheathing cells. Infection and Immunity, 84 (7), 1941-1956. doi: 10.1128/IAI.01546-15
Funding
Current funding
Supervision
Availability
- Dr Emily Strong is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Boosting BCG: The use of Potent Immunostimulatory Secreted Antigens of Mycobacterium tuberculosis.
Associate Advisor
Other advisors: Professor Nick West
Media
Enquiries
For media enquiries about Dr Emily Strong's areas of expertise, story ideas and help finding experts, contact our Media team: